Table 3

Distribution and risk associated with sIL-2R levels at different stages of cervical neoplasia

sIL-2R(units/ml)Controls NLSIL (n = 176) vs. Controls (n = 112)HSIL (n = 121) vs. LSIL (n = 176)Cancer (n = 36) vs. HSIL (n = 121)
ORa95% CIOR95% CIOR95% CI
Quartile 1(0–439)30refrefref
Quartile 2(440–579)262.00.96–4.1)1.4(0.67–2.9)0.71(0.16–3.1)
Quartile 3(580–734)281.6(0.75–3.4)1.2(0.55–2.6)1.8(0.45–7.1)
Quartile 4(735+)282.3(1.1–5.2)1.1(0.47–2.4)1.8(0.47–7.1)
  • a Adjusted for age.